NCT01655381 A Long-Term Extension Study of WA19926 on the Safety of Tocilizumab (RoActemra/Actemra) in Participants With Early Moderate to Severe Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01652937 BIIB057 in Subjects With Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs Status WITHDRAWN Phase PHASE2
NCT01651936 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial to Evaluate the Safety, Tolerability, and Efficacy of MK-8457 in Participants With Rheumatoid Arthritis (MK-8457-010) Status TERMINATED Phase PHASE2
NCT01649817 A Retrospective Observational Study on Compliance in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab) in Clinical Practice (REMISSION II) Status COMPLETED Phase N/A
NCT01649804 A Long-Term Safety Extension Study of WA19926 in Participants With Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01647451 A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy of NNC0114-0006 in Subjects With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT01646385 Study to Assess the Safety and Efficacy of Etanercept in Patients Treated Over the Long-term in Real-world Clinical Practice, Using Data Collected by the British Society of Rheumatology Biologics Registry Status COMPLETED Phase N/A
NCT01643928 Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04) Status COMPLETED Phase NA
NCT01643863 A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis (MONACO) Status TERMINATED Phase N/A
NCT01642706 Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments Status UNKNOWN Phase N/A
NCT01641952 An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response or Intolerance to One Anti-Tumor Necrosis Factor (Anti-TNF) Agent Status COMPLETED Phase N/A
NCT01641705 Analysis of Respiratory Mechanics in Patients With Rheumatoid Arthritis Status UNKNOWN Phase N/A
NCT01640548 A Retrospective Chart Review on the Use of Biologics in Monotherapy for the Treatment of Patients With Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT01640054 A Long Term Study to Assess the Safety of Fostamatinib in Patients in Asia With Rheumatoid Arthritis Status TERMINATED Phase PHASE2
NCT01638715 A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of Action Status COMPLETED Phase PHASE4
NCT01636843 A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate Status TERMINATED Phase PHASE2
NCT01636817 A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics Status TERMINATED Phase PHASE2
NCT01635686 Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male Volunteers Status UNKNOWN Phase PHASE1
NCT01635582 Home Based Computer Gaming Hand Exercise Regimen for People With Arthritis Affecting the Hands Status COMPLETED Phase PHASE2
NCT01635166 Multi-centre Study to Assess the Long-term Performance of the Deltamotion Cup System in Primary Hip Replacement Surgery Status TERMINATED Phase PHASE4